378 related articles for article (PubMed ID: 15725261)
1. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
Finucane KA; Archer CB
Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
[No Abstract] [Full Text] [Related]
2. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
3. Management of rheumatoid arthritis.
Handa R
Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
[TBL] [Abstract][Full Text] [Related]
4. Innovative treatment strategies for patients with rheumatoid arthritis.
van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in biological agent naive patients with psoriatic arthritis.
Johnson SR; Schentag CT; Gladman DD
Ann Rheum Dis; 2005 May; 64(5):770-2. PubMed ID: 15834057
[TBL] [Abstract][Full Text] [Related]
6. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
Turkiewicz AM; Moreland LW
Arthritis Rheum; 2007 Apr; 56(4):1051-66. PubMed ID: 17393414
[No Abstract] [Full Text] [Related]
7. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
Russell AS; Maksymowych WP; de Silva M
Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
[No Abstract] [Full Text] [Related]
8. The NICE reappraisal of biologics in 2005: what rheumatologists need to know.
Bansback NJ; Young A; Brennan A
Rheumatology (Oxford); 2005 Jan; 44(1):3-4. PubMed ID: 15328422
[No Abstract] [Full Text] [Related]
9. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
11. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
[TBL] [Abstract][Full Text] [Related]
12. Etanercept-associated SLE with lupus nephritis.
Neradová A; Stam F; van den Berg JG; Bax WA
Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
[No Abstract] [Full Text] [Related]
13. Anti-tumor necrosis factor agents are mostly used in patients with established rheumatoid arthritis compared to early disease -- a reflection of adequate clinical practice.
Haraoui B
J Rheumatol; 2009 Aug; 36(8):1561-2. PubMed ID: 19671804
[No Abstract] [Full Text] [Related]
14. Recent therapeutic advances in the treatment of rheumatoid arthritis.
Jonas BL
N C Med J; 2007; 68(6):425-6. PubMed ID: 18236860
[No Abstract] [Full Text] [Related]
15. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
16. [Biological treatment of rare inflammatory rheumatic diseases].
Baslund B
Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
[TBL] [Abstract][Full Text] [Related]
17. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
[No Abstract] [Full Text] [Related]
18. Anti-TNF-induced lupus.
Williams EL; Gadola S; Edwards CJ
Rheumatology (Oxford); 2009 Jul; 48(7):716-20. PubMed ID: 19416947
[TBL] [Abstract][Full Text] [Related]
19. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
Weisman MH
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
[No Abstract] [Full Text] [Related]
20. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
